BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turdo A, D'Accardo C, Glaviano A, Porcelli G, Colarossi C, Colarossi L, Mare M, Faldetta N, Modica C, Pistone G, Bongiorno MR, Todaro M, Stassi G. Targeting Phosphatases and Kinases: How to Checkmate Cancer. Front Cell Dev Biol 2021;9:690306. [PMID: 34778245 DOI: 10.3389/fcell.2021.690306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shah DD, Dave BP, Patel PA, Chorawala MR, Patel VN, Shah PA, Patel MP. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities. Med Oncol 2023;40:84. [PMID: 36680649 DOI: 10.1007/s12032-023-01948-4] [Reference Citation Analysis]
2 Min J, Chun K, Kim D. The versatile utility of cysteine as a target for cancer treatment. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.997919] [Reference Citation Analysis]
3 De Rasmo D, Cormio A, Cormio G, Signorile A. Ovarian Cancer: A Landscape of Mitochondria with Emphasis on Mitochondrial Dynamics. Int J Mol Sci 2023;24. [PMID: 36674740 DOI: 10.3390/ijms24021224] [Reference Citation Analysis]
4 D’accardo C, Porcelli G, Mangiapane LR, Modica C, Pantina VD, Roozafzay N, Di Franco S, Gaggianesi M, Veschi V, Lo Iacono M, Todaro M, Turdo A, Stassi G. Cancer cell targeting by CAR-T cells: A matter of stemness. Front Mol Med 2022;2. [DOI: 10.3389/fmmed.2022.1055028] [Reference Citation Analysis]
5 Majumder S, Manna SK. Rewiring of Drug Metabolism and Its Cross‐talk with Metabolic Reprogramming in Cancer. Drug Metabolism Handbook 2022. [DOI: 10.1002/9781119851042.ch27] [Reference Citation Analysis]
6 Nair VA, Malhab LJB, Abdel-Rahman WM. Characterization of the Molecular Alterations Induced by the Prolonged Exposure of Normal Colon Mucosa and Colon Cancer Cells to Low-Dose Bisphenol A. Int J Mol Sci 2022;23:11620. [PMID: 36232920 DOI: 10.3390/ijms231911620] [Reference Citation Analysis]
7 Clausse V, Fang Y, Tao D, Tagad HD, Sun H, Wang Y, Karavadhi S, Lane K, Shi Z, Vasalatiy O, Leclair CA, Eells R, Shen M, Patnaik S, Appella E, Coussens NP, Hall MD, Appella DH. Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00147] [Reference Citation Analysis]
8 Joshi RS, Esteller M. Cellular and clinical impact of Protein Phosphatase Enzyme epigenetic silencing in multiple cancer tissues.. [DOI: 10.1101/2022.03.03.482850] [Reference Citation Analysis]
9 Salvati A, Poelstra K. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation. Pharmaceutics 2022;14:217. [DOI: 10.3390/pharmaceutics14010217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nunes-xavier CE, Zaldumbide L, Mosteiro L, López-almaraz R, García de Andoin N, Aguirre P, Emaldi M, Torices L, López JI, Pulido R. Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets. Front Cell Dev Biol 2021;9:811297. [DOI: 10.3389/fcell.2021.811297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]